Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 563, pseudogene (RNU6-563P) is a human pseudogene annotated in genome databases such as Ensembl and HGNC, located on chromosome 20. As a pseudogene, it is a non-coding copy derived from the U6 small nuclear RNA gene family which has lost its protein-coding potential through disabling mutations or truncations[1][3][9]. Pseudogenes like RNU6-563P generally do not produce functional proteins; however, some can be transcribed and may participate in regulatory roles at the RNA level, such as interacting with parental genes or serving as competing endogenous RNAs, though no such functions are established for RNU6-563P specifically[6]. It has not been implicated as a direct target for therapeutic intervention nor associated with human disease, and no drugs, biomarkers, or safety concerns are reported for this locus[9]. Its scientific relevance is limited to understanding genomic architecture and non-coding RNA biology.
None known. No drugs target this locus, so no mechanism of action is described for RNU6-563P
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 563, pseudogene (RNU6-563P).